Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | CD44 | P16070 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24039980 | 0.79 | CYP3A4 (0.50) | CYP3A4ALDH1A1GAAKDM4ECD44 | |
| SCHEMBL3668733 | 0.78 | GAA (0.42) | CYP3A4ALDH1A1GAANPC1CD44 | |
| SCHEMBL9361882 | 0.77 | TAAR1 (0.34) | CYP3A4ALDH1A1GAAKDM4ETSHR | |
| SCHEMBL4592068 | 0.77 | POLB (0.44) | CYP3A4ALDH1A1LMNATSHRGRIN2D | |
| SCHEMBL24603696 | 0.75 | CYP3A4 (0.36) | CYP3A4ALDH1A1KDM4ELMNAADRB1 | |
| SCHEMBL18112469 | 0.74 | CYP3A4 (0.50) | CYP3A4ALDH1A1NPC1LMNAHTR1A | |
| SCHEMBL9187701 | 0.74 | SIRT1 (0.32) | CYP3A4NPC1LMNAHTR1ASLC6A2 | |
| SCHEMBL8960982 | 0.73 | GAA (0.42) | CYP3A4ALDH1A1GAANPC1CD44 | |
| SCHEMBL3669302 | 0.73 | CYP3A4 (0.35) | CYP3A4ALDH1A1GAACD44HTR1A | |
| SCHEMBL841170 | 0.73 | NOS2 (0.35) | NOS3NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9193667-B2 | Process for the selective meta-chlorination of alkylanilines | LONZA LTD. (CH) | 2015-11-24 | — | — | US | disclosed |
| US-20130338400-A1 | PROCESS FOR THE SELECTIVE META-CHLORINATION OF ALKYLANILINES | LONZA LTD. (CH) | 2013-12-19 | — | — | US | disclosed |
| US-8536242-B2 | Photocurable composition | SEKISUI CHEMICAL CO., LTD. (JP) | 2013-09-17 | — | — | US | disclosed |
| EP-2606028-A1 | PROCESS FOR THE SELECTIVE META-CHLORINATION OF ALKYLANILINES | Lonza Ltd (CH) | 2013-06-26 | — | — | EP | disclosed |
| WO-2012022460-A1 | PROCESS FOR THE SELECTIVE META-CHLORINATION OF ALKYLANILINES | LONZA LTD (CH) | 2012-02-23 | — | — | WO | disclosed |
| US-20110097669-A1 | PHOTOCURABLE COMPOSITION | SEKISUI CHEMICAL CO., LTD. (JP) | 2011-04-28 | — | — | US | disclosed |
| US-20070072096-A1 | Negative curable dye-containing composition, color filter, and method of manufacturing the same | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130338400-A1 | PROCESS FOR THE SELECTIVE META-CHLORINATION OF ALKYLANILINES | CLIC4, CLIC1, NPM1 | CYP3A4 54/4885ALDH1A1 2408/4885GAA 2069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.